The effect of Mepilex dressings on radiation-induced skin reactions in women with breast cancer
The effect of mepilex lite dressings on the management of radiation-induced skin reactions in women with breast cancer
University of Otago, Wellington
40 participants
Jun 2, 2008
Interventional
Conditions
Summary
Radiation therapy of the breast aims to eradicate all possible remaining tumour cells and, in addition, can cause skin reactions, varying from a slight reddening of the skin to itching, cracking, blistering or peeling, leaving the underlying tissues exposed. Although there are several ways to manage radiation-induced skin reactions, there is currently no standard protocol in New Zealand. A promising new range of Swedish silicon-foam skin dressings, (Mepilex Lite, Molnlycke), is currently in use in many hospitals in New Zealand for the treatment of burns. This project aims to investigate the cooling effects of the dressings on radiation-induced skin reactions in 40 women undergoing radiation treatment for breast cancer in Dunedin Hospital. When reddening of the skin is seen, several parts of the irradiated breast area will be covered with dressings, whilst the other parts will be treated with a moisturizing cream. Skin condition will be assessed three times a week for the duration of treatment, as well as 1 and 4 weeks after treatment has been completed, using an established skin assessment scale, digital photographs and heat measurements.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Mepilex Lite dressings consist of a thin flexible foam with silicon webbing which does not react with chemicals in and on the skin. The dressings will be used to cover parts of skin that shows signs of radiation-induced skin reactions (mild erythema). Progression from mild to severe erythema and to dry desquamation will be monitored and compared to parts of the irradiated skin that is treated with standard skin care (in-patient controls). The dressings will be applied from the moment erythema is seen (usually 2 weeks into the 5 week treatment). They will be replaced weekly for the duration of the treatment and for four weeks after treatment has been completed.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12608000180314